Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 8/20 | 0.88 |
| ▸ | CYP1B1 | Q16678 | 7/20 | 0.88 |
| ▸ | CYP1A1 | P04798 | 6/20 | 0.88 |
| ▸ | P4HB | P07237 | 2/20 | 0.74 |
| ▸ | MAPT | P10636 | 2/20 | 0.68 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | BCHE | P06276 | 1/20 | 0.68 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.68 |
| ▸ | ACHE | P22303 | 1/20 | 0.68 |
| ▸ | RECQL | P46063 | 1/20 | 0.68 |
| ▸ | PLIN5 | Q00G26 | 1/20 | 0.68 |
| ▸ | ABHD5 | Q8WTS1 | 1/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.65 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.65 |
| ▸ | PKM | P14618 | 1/20 | 0.65 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.65 |
| ▸ | RAB9A | P51151 | 1/20 | 0.65 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.65 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL657574 | 1.00 | MAOB (0.88) | MAOBCYP1B1CYP1A1P4HBMAPT | |
| SCHEMBL11797187 | 1.00 | MAOB (0.88) | MAOBCYP1B1CYP1A1P4HBMAPT | |
| SCHEMBL658580 | 0.93 | CYP1B1 (1.00) | MAOBCYP1B1CYP1A1P4HBMAPT | |
| SCHEMBL658579 | 0.93 | CYP1B1 (1.00) | MAOBCYP1B1CYP1A1P4HBMAPT | |
| SCHEMBL11816718 | 0.91 | CYP1A1 (0.87) | MAOBCYP1B1CYP1A1P4HBMAPT | |
| SCHEMBL11816722 | 0.91 | CYP1A1 (0.87) | MAOBCYP1B1CYP1A1P4HBMAPT | |
| Hydrochloric Acid SCHEMBL11819375 | 0.90 | CYP1A1 (0.84) | MAOBCYP1B1CYP1A1P4HBMAPT | |
| Bromide SCHEMBL11817521 | 0.90 | CYP1A1 (0.84) | MAOBCYP1B1CYP1A1P4HBMAPT | |
| Bromide SCHEMBL11817515 | 0.90 | CYP1A1 (0.84) | MAOBCYP1B1CYP1A1P4HBMAPT | |
| Hydrochloric Acid SCHEMBL11819369 | 0.90 | CYP1A1 (0.84) | MAOBCYP1B1CYP1A1P4HBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119192224-A | Alpha, beta-unsaturated ketone cyano silanization method and application | 哈尔滨理工大学 | 2024-12-27 | — | — | CN | claimed |
| CN-104030984-B | A kind of preparation method of pyrazole derivatives | 甘肃农业大学 | 2016-07-13 | — | — | CN | claimed |
| CN-119192224-A | Alpha, beta-unsaturated ketone cyano silanization method and application | 哈尔滨理工大学 | 2024-12-27 | — | — | CN | disclosed |
| US-11661407-B2 | Process for the preparation of pyrylium salts | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2023-05-30 | — | — | US | disclosed |
| CN-114805044-A | Novel method for synthesizing dibromo compound | 兰州大学 | 2022-07-29 | — | — | CN | disclosed |
| US-20210087158-A1 | A PROCESS FOR THE PREPARATION OF PYRYLIUM SALTS | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2021-03-25 | — | — | US | disclosed |
| US-10737995-B2 | Nuclear receptor modulators and their use for the treatment and prevention of cancer | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2020-08-11 | — | — | US | disclosed |
| CN-105524110-B | A kind of synthetic method of the haloalkyl alcohol ester of alkene | 中国科学院大连化学物理研究所 | 2019-02-19 | — | — | CN | disclosed |
| US-20190047932-A1 | NUCLEAR RECEPTOR MODULATORS AND THEIR USE FOR THE TREATMENT AND PREVENTION OF CANCER | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERV (US) | 2019-02-14 | — | — | US | disclosed |
| CN-104030984-B | A kind of preparation method of pyrazole derivatives | 甘肃农业大学 | 2016-07-13 | — | — | CN | disclosed |
| EP-2349999-B1 | ALLOSTERIC PROTEIN KINASE MODULATORS | UNIV SAARLAND (DE) | 2016-01-27 | — | — | EP | disclosed |
| WO-2012116362-A2 | CHALCONE DERIVATIVES AS NRF2 ACTIVATORS | THE JOHNS HOPKINS UNIVERSITY (US) | 2012-08-30 | — | — | WO | disclosed |
| US-20120046307-A1 | ALLOSTERIC PROTEIN KINASE MODULATORS | UNIVERSITAET DES SAARLANDES (DE) | 2012-02-23 | — | — | US | disclosed |
| EP-2349999-A1 | ALLOSTERIC PROTEIN KINASE MODULATORS | Universität des Saarlandes (DE) | 2011-08-03 | — | — | EP | disclosed |
| WO-2010043711-A1 | ALLOSTERIC PROTEIN KINASE MODULATORS | UNIVERSITAET DES SAARLANDES (DE) | 2010-04-22 | — | — | WO | disclosed |
| EP-2177510-A1 | Allosteric protein kinase modulators | Universität des Saarlandes (DE) | 2010-04-21 | — | — | EP | disclosed |
| US-5492915-A | ANTIINFLAMMATORY AGENTS | RHONE-POULENC RORER S.A. (FR) | 1996-02-20 | — | — | US | disclosed |
| US-5366982-A | Antiinflammatory agents or antihistamines | RHONE-POULENC RORER S.A. (FR) | 1994-11-22 | — | — | US | disclosed |
| EP-0540604-A1 | SUBSTITUTED BICYCLIC BIS-ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B 4? ANTAGONIST ACTIVITY, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS | Aventis Pharma S.A. (FR) | 1993-05-12 | — | — | EP | disclosed |
| WO-1992001675-A2 | SUBSTITUTED BICYCLIC BIS-ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B4 ANTAGONIST ACTIVITY, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS | RHONE-POULENC RORER S.A. (FR) | 1992-02-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210087158-A1 | A PROCESS FOR THE PREPARATION OF PYRYLIUM SALTS | IPO5, SF3B5, CYP4F11 | MAOB 2307/4885CYP1B1 110/4885CYP1A1 275/4885 |
| US-20190047932-A1 | NUCLEAR RECEPTOR MODULATORS AND THEIR USE FOR THE TREATMENT AND PREVENTION OF CANCER | AR, NCOA1, NR5A1 | MAOB 3966/4885CYP1B1 488/4885CYP1A1 244/4885 |
| US-20120046307-A1 | ALLOSTERIC PROTEIN KINASE MODULATORS | AURKC, AURKA, AURKB | MAOB 4512/4885CYP1B1 4714/4885CYP1A1 4763/4885 |
| US-10737995-B2 | Nuclear receptor modulators and their use for the treatment and prevention of cancer | AR, NCOA1, NR5A1 | MAOB 3966/4885CYP1B1 488/4885CYP1A1 244/4885 |
| US-11661407-B2 | Process for the preparation of pyrylium salts | SF3B5, IPO5, CYP4F11 | MAOB 2613/4885CYP1B1 139/4885CYP1A1 337/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.